is incredibly Chlorpheniramine / Methscopolamine / Phenylephrine Dosage Overview Side Effects Dosage Interactions Pregnancy More User Reviews Drug Images Support Group Q & A Applies to the following strength(s): 2 mg-0.625 mg-10 mg/5 mL ; 8 mg-2.5 mg-20 mg ; 2 mg-1.25 mg-10 mg/5 mL ; 2 mg-1.25 mg-10 mg ; 4 mg-1.25 mg-10 mg ; 12 mg-2.5 mg-20 mg ; ages 12 years and older ; 2 mg-0.75 mg-8 mg/5 mL ; 2 mg-0.75 mg-10 mg/5 mL ; 4 mg-1.25 mg-10 mg/ 5 mL ; 8 mg-1.25 mg-20 mg ; 2 mg-1.5 mg-10 mg/5 mL ; 8 mg-2.5 mg-25 mg ; 2 mg-1.25 mg-15 mg ; 2 mg-1.5 mg-10 mg ; ages 6 years and older ; 8 mg-2.5 mg-40 mg ; 12 mg-2 mg-40 mg The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist. Usual Adult Dose for: Nasal Congestion Rhinitis Usual Pediatric Dose for: Nasal Congestion Rhinitis Additional dosage information: Renal Dose Adjustments Liver Dose Adjustments Dialysis Usual Adult Dose for Nasal Congestion Tablets : chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release : 1 tablet orally twice a day, not to exceed 2 doses per day. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day. chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release: chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening. chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening. Liquid : chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily. chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day. chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily. Usual Adult Dose for Rhinitis Tablets : chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release : 1 tablet orally twice a day, not to exceed 2 doses per day. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day. chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release: chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening. chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening. Liquid : chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily. chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day. chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily. Usual Pediatric Dose for Nasal Congestion 12 yrs and older : Tablets: chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release: 1 tablet orally twice a day, not to exceed 2 doses per day. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day. chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release: chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening. chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening. Liquid: chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily. chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day. chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily. 6 yrs to 11 yrs : Liquid : chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily. Chew tab : chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day. Tablets : chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release : 1/2 tablet orally twice daily, not to exceed 2 doses per day. chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day. chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening. Usual Pediatric Dose for Rhinitis 12 yrs and older : Tablets: chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release: 1 tablet orally twice a day, not to exceed 2 doses per day. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day. chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release: chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening. chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening. Liquid: chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily. chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day. chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily. 6 yrs to 11 yrs : Liquid : chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours. chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily. Chew tab : chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day. Tablets : chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release : 1/2 tablet orally twice daily, not to exceed 2 doses per day. chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day. chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening. Renal Dose Adjustments Data not available Liver Dose Adjustments Data not available Dialysis Data not available Next Interactions Print this page Add to My Med List More about chlorpheniramine/methscopolamine/phenylephrine Side Effects During Pregnancy Dosage Information Drug Images Drug Interactions Support Group En Español 5 Reviews Add your own review/rating Drug class: upper respiratory combinations Consumer resources Chlorpheniramine, methscopolamine, and phenylephrine Other brands: AH-Chew II Professional resources Related treatment guides Nasal Congestion Rhinitis} Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug WADA Class Anti-Doping Classification Drug Class Upper respiratory combinations Related Drugs Nasal Congestion sodium chloride nasal , epinephrine topical , pseudoephedrine , phenylephrine , Afrin , doxylamine , Sudafed Congestion , Claritin-D , loratadine / pseudoephedrine , Loratadine-D 24 Hour , Saline Nasal Mist , More... Rhinitis fluticasone nasal , Flonase , Flonase Allergy Relief , Veramyst , Flonase Sensimist , Rynex PE , RespiVent DF , More... Chlorpheniramine / methscopolamine / phenylephrine Rating 5 User Reviews 9.0 /10 5 User Reviews 9.0 Rate it! Chlorpheniramine / methscopolamine / phenylephrine Images Chlorpheniramine / methscopolamine / phenylephrine systemic chlorpheniramine 4 mg / methscopolamine 1.25 mg / phenylephrine 10 mg (LASER DALLERGY ) View larger images} } numerous
area of expertise Chlorpheniramine / Methscopolamine / Phenylephrine Dosage clash
EmoticonEmoticon